Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Annual Trading Update

7 Oct 2010 07:00

RNS Number : 9858T
Victrex PLC
07 October 2010
 



For Stock Exchange release at 7.00a.m. Thursday 7 October 2010

 

Victrex plc

 

Annual Trading Update

 

The Company announces its trading update for the year ended 30 September 2010.

 

Full year Group sales volume amounted to approximately 2,535 tonnes, an increase of 64% over the previous year (1,547 tonnes) with a half year record of 1,364 tonnes in the second half. Sales volume for October has started strongly, continuing to reinforce the positive underlying trends in the Victrex Polymer Solutions ('VPS') business.

 

Full year revenue for Invibio®, our biomaterial solutions business, was in line with our expectations at approximately £44.2m, an increase of 29% over the previous year (£34.2m). Underlying Invibio revenue (at constant exchange rates) was up 15% on last year.

 

Overall, we expect Group profits for 2010 to be in line with market expectations.

 

Victrex will announce its results for the year ended 30 September 2010 on Tuesday 7 December 2010.

 

 

Enquiries

 

 

Victrex plc

Michael Peacock, Finance Director

 0207 357 9477 (7 October 2010)

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne

0207 357 9477

 

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. We work with customers and end users to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions division ('VPS') focuses on our transport, industrial and electronics markets and our Invibio Biomaterial Solutions division ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKADDABDDDKK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.